Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
REDWOOD CITY, Calif., July 10, 2024 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second… Read More »Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
